The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Immunotherapy of cancer with dendritic-cell-based vaccines
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Proliferating dendritic cell progenitors in human blood.
Romani, N., Gruner, S., Brang, D., Kämpgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P. O., Steinman, R. M., & Schuler, G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.83 · Cited by 1,840
Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
Huang, A. Y. C., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., & Levitsky, H. (1994) · Science · doi:10.1126/science.7513904 · Cited by 1,160
Maraskovsky, E., Brasel, K., Teepe, M., Roux, E. R., Lyman, S. D., Shortman, K., & McKenna, H. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.1953 · Cited by 1,115
Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.
Boczkowski, D., Nair, S. K., Snyder, D., & Gilboa, E. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.465 · Cited by 915
Self-citationHuman tumor antigens recognized by T lymphocytes.
Boon, T., & van der Bruggen, P. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.725 · Cited by 842
Zitvogel, L., Mayordomo, J. I., Tjandrawan, T., DeLeo, A. B., Clarke, M. R., Lotze, M. T., & Storkus, W. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.1.87 · Cited by 828
Ikeda, H., Lethé, B., Lehmann, F., Van Baren, N., Baurain, J.-F., De Smet, C., Chambost, H., Vitale, M., Moretta, A., Boon, T., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80426-4 · Cited by 762
Gansbacher, B., Zier, K., Daniels, B., Cronin, K., Bannerji, R., & Gilboa, E. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.4.1217 · Cited by 620
Self-citationGreenberg, P. D. (1991) · Advances in Immunology · doi:10.1016/s0065-2776(08)60778-6 · Cited by 603
In Vivo Detection of Dendritic Cell Antigen Presentation to CD4+ T Cells
Ingulli, E., Mondino, A., Khoruts, A., & Jenkins, M. K. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.12.2133 · Cited by 546
Cardin, R. D., Brooks, J. W., Sarawar, S. R., & Doherty, P. C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.863 · Cited by 501
Helper activity is required for the in vivo generation of cytotoxic T lymphocytes
Keene, J.-A., & Forman, J. (1982) · The Journal of Experimental Medicine · doi:10.1084/jem.155.3.768 · Cited by 500
Cancer antigens: immune recognition of self and altered self.
Houghton, A. N. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.1 · Cited by 420
Tolerance, Danger and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.991 · Cited by 335
von Herrath, M. G., Yokoyama, M., Dockter, J., Oldstone, M. B., & Whitton, J. L. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.1072-1079.1996 · Cited by 279
Tumor Eradication by Wild-type p53-specific Cytotoxic T Lymphocytes
Vierboom, M. P. M., Nijman, H. W., Offringa, R., Voort, E. I. H. V. D., Hall, T. V., Broek, L. V. D., Fleuren, G. J., Kenemans, P., Kast, W. M., & Melief, C. J. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.5.695 · Cited by 206
The Dendritic Cell System And Its Role In Immunogenicity
Steinman, R. M. (1991) · Annual Review of Immunology · doi:10.1146/annurev.immunol.9.1.271 · Cited by 164
Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo?
Huang, A. Y.-C., Bruce, A. T., Pardoll, D. M., & Levitsky, H. I. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.3.769 · Cited by 140
Gene Transfer as Cancer Therapy
Dranoff, G., & Mulligan, R. C. (1995) · Advances in immunology · doi:10.1016/s0065-2776(08)60624-0 · Cited by 135
Dendritic cells hold promise for immunotherapy
Girolomoni, G., & Ricciardi‐Castagnoli, P. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01030-x · Cited by 134
Johnston, J. V., Malacko, A. R., Mizuno, M. T., McGowan, P., Hellström, I., Hellström, K. E., Marquardt, H., & Chen, L. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.3.791 · Cited by 96
Rock, K. L., & Clark, K. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.10.3721 · Cited by 91
Anichini, A., Mortarini, R., Maccalli, C., Squarcina, P., Fleischhauer, K., Mascheroni, L., & Parmiani, G. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.1.208 · Cited by 91
Melero, I., Singhal, M. C., McGowan, P., Haugen, H. S., Blake, J., Hellström, K. E., Yang, G., Clegg, C. H., & Chen, L. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.3998-4004.1997 · Cited by 85
Parmiani, G. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90183-l · Cited by 71
Cited by
Dendritic cells as therapeutic vaccines against cancer
Banchereau, J., & Palucka, A. K. (2005) · Nature Reviews Immunology · doi:10.1038/nri1592 · Cited by 1,204
Dendritic cell immunotherapy: mapping the way
Figdor, C. G., de Vries, I. J. M., Lesterhuis, W. J., & Melief, C. J. M. (2004) · Nature Medicine · doi:10.1038/nm1039 · Cited by 945
Heiser, A., Coleman, D., Dannull, J., Yancey, D., Maurice, M. A., Lallas, C. D., Dahm, P., Niedzwiecki, D., Gilboa, E., & Vieweg, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214364 · Cited by 562
Self-citationDistinct Role of Antigen-Specific T Helper Type 1 (Th1) and Th2 Cells in Tumor Eradication in Vivo
Nishimura, T., Iwakabe, K., Sekimoto, M., Ohmi, Y., Yahata, T., Nakui, M., Sato, T., Habu, S., Tashiro, H., Sato, M., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.5.617 · Cited by 468
The Makings of a Tumor Rejection Antigen
Gilboa, E. (1999) · Immunity · doi:10.1016/s1074-7613(00)80101-6 · Cited by 381
Self-citation
Metadata
- Authors
- Gilboa, E., Nair, S. K., & Lyerly, H. K.
- Venue
- Cancer Immunology, Immunotherapy
- Published
- 1998-04
- Volume
- 46
- Issue
- 2
- Pages
- 82-87
- ISSN
- 0340-7004 (ISSN-L)
- 1432-0851
- OpenAlex
- W2038300953
- Cited by
- 287
- References
- 25
- FWCI
- 9.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.